{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:17:05Z","timestamp":1760955425415},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T00:00:00Z","timestamp":1367280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/nrcardio.2013.63","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T10:18:53Z","timestamp":1367317133000},"page":"422-427","source":"Crossref","is-referenced-by-count":6,"title":["New directions in immunosuppression after heart transplantation"],"prefix":"10.1038","volume":"10","author":[{"given":"David A.","family":"Baran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"key":"BFnrcardio201363_CR1","first-page":"1271","volume":"41","author":"CN Barnard","year":"1967","unstructured":"Barnard, C. N. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S. Afr. Med. J. 41, 1271\u20131274 (1967).","journal-title":"S. Afr. Med. J."},{"key":"BFnrcardio201363_CR2","first-page":"441","volume":"3","author":"SV Lawrence","year":"1980","unstructured":"Lawrence, S. V. Heart transplants: blessing or boondoggle? Forum Med. 3, 441\u2013445 (1980).","journal-title":"Forum Med."},{"key":"BFnrcardio201363_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.1973.03220300044010","volume":"225","author":"PK Caves","year":"1973","unstructured":"Caves, P. K.  et al. Percutaneous transvenous endomyocardial biopsy. JAMA 225, 288\u2013291 (1973).","journal-title":"JAMA"},{"key":"BFnrcardio201363_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/01.CIR.52.4.531","volume":"52","author":"AK Ridker","year":"1975","unstructured":"Ridker, A. K.  et al. The status of cardiac transplantation, 1975. Circulation 52, 531\u2013539 (1975).","journal-title":"Circulation"},{"key":"BFnrcardio201363_CR5","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1056\/NEJM198005083021912","volume":"302","author":"A Leaf","year":"1980","unstructured":"Leaf, A. Sounding board: the MGH trustees say no to heart transplants. N. Engl. J. Med. 302, 1087\u20131088 (1980).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201363_CR6","first-page":"627","volume":"14","author":"PF Halloran","year":"1982","unstructured":"Halloran, P. F., Lien, J., Aprile, M. & White, N. Preliminary results of a randomized comparison of cyclosporine and Minnesota Antilymphoblast Globulin. Transplant. Proc. 14, 627\u2013630 (1982).","journal-title":"Transplant. Proc."},{"key":"BFnrcardio201363_CR7","first-page":"252","volume":"27","author":"R Devineni","year":"1984","unstructured":"Devineni, R.  et al. Cyclosporine in cardiac transplantation. Can. J. Surg. 27, 252\u2013254 (1984).","journal-title":"Can. J. Surg."},{"key":"BFnrcardio201363_CR8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.healun.2012.08.002","volume":"31","author":"J Stehlik","year":"2012","unstructured":"Stehlik, J.  et al. The registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report\u20142012. J. Heart Lung Transplant. 31, 1052\u20131064 (2012).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio201363_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","volume":"66","author":"J Kobashigawa","year":"1998","unstructured":"Kobashigawa, J.  et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation 66, 507\u2013515 (1998).","journal-title":"Transplantation"},{"key":"BFnrcardio201363_CR10","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1600-6143.2006.01297.x","volume":"6","author":"JA Kobashigawa","year":"2006","unstructured":"Kobashigawa, J. A.  et al. Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial. Am. J. Transplant. 6, 993\u2013997 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrcardio201363_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJMoa022171","volume":"349","author":"HJ Eisen","year":"2003","unstructured":"Eisen, H. J.  et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N. Engl. J. Med. 349, 847\u2013858 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201363_CR12","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.jacc.2005.02.035","volume":"45","author":"JA Kobashigawa","year":"2005","unstructured":"Kobashigawa, J. A.  et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J. Am. Coll. Cardiol. 45, 1532\u20131537 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201363_CR13","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","volume":"6","author":"JA Kobashigawa","year":"2006","unstructured":"Kobashigawa, J. A.  et al. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am. J. Transplant. 6, 1377\u20131386 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrcardio201363_CR14","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/j.1600-6143.2006.01300.x","volume":"6","author":"M Grimm","year":"2006","unstructured":"Grimm, M.  et al. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients\u2014a large European trial. Am. J. Transplant. 6, 1387\u20131397 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrcardio201363_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.hfc.2007.02.009","volume":"3","author":"DA Baran","year":"2007","unstructured":"Baran, D. A. Induction therapy in cardiac transplantation: when and why? Heart Fail. Clin. 3, 31\u201341 (2007).","journal-title":"Heart Fail. Clin."},{"key":"BFnrcardio201363_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.healun.2007.01.002","volume":"26","author":"PA Uber","year":"2007","unstructured":"Uber, P. A. & Mehra, M. R. Induction therapy in heart transplantation: is there a role? J. Heart Lung Transplant. 26, 205\u2013209 (2007).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio201363_CR17","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1056\/NEJMoa032953","volume":"352","author":"RE Hershberger","year":"2005","unstructured":"Hershberger, R. E.  et al. Daclizumab to prevent rejection after cardiac transplantation. N. Engl. J. Med. 352, 2705\u20132713 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201363_CR18","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/00007890-200210270-00014","volume":"74","author":"DA Baran","year":"2002","unstructured":"Baran, D. A.  et al. Tacrolimus in cardiac transplantation: efficacy and safety of a novel dosing protocol. Transplantation 74, 1136\u20131141 (2002).","journal-title":"Transplantation"},{"key":"BFnrcardio201363_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1053-2498(00)00237-0","volume":"20","author":"DA Baran","year":"2001","unstructured":"Baran, D. A.  et al. Tacrolimus monotherapy inadult cardiac transplant recipients: intermediate-term results. J. Heart Lung Transplant. 20, 59\u201370 (2001).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio201363_CR20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.healun.2006.02.003","volume":"25","author":"SA Lubitz","year":"2006","unstructured":"Lubitz, S. A.  et al. Long-term results of tacrolimus monotherapy in cardiac transplant recipients. J. Heart Lung Transplant. 25, 699\u2013706 (2006).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio201363_CR21","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.healun.2007.07.022","volume":"26","author":"DA Baran","year":"2007","unstructured":"Baran, D. A.  et al. Randomized trial of tacrolimus monotherapy: tacrolimus in combination, tacrolimus alone compared (the TICTAC trial). J. Heart Lung Transplant. 26, 992\u2013997 (2007).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio201363_CR22","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9149(99)80432-9","volume":"75","author":"MR Mehra","year":"1995","unstructured":"Mehra, M. R.  et al. An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy. Am. J. Cardiol. 75, 853\u2013854 (1995).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201363_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S1053-2498(03)00189-X","volume":"23","author":"MH Yamani","year":"2004","unstructured":"Yamani, M. H.  et al. Does acute cellular rejection correlate with cardiac allograft vasculopathy? J. Heart Lung Transplant. 23, 272\u2013276 (2004).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio201363_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1161\/CIRCHEARTFAILURE.110.958520","volume":"4","author":"DA Baran","year":"2011","unstructured":"Baran, D. A.  et al. A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial. Circ. Heart Fail. 4, 129\u2013137 (2011).","journal-title":"Circ. Heart Fail."},{"key":"BFnrcardio201363_CR25","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1097\/01.tp.0000210538.93861.ae","volume":"81","author":"B Dresske","year":"2006","unstructured":"Dresske, B.  et al. WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients. Transplantation 81, 1549\u20131557 (2006).","journal-title":"Transplantation"},{"key":"BFnrcardio201363_CR26","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/00007890-199405270-00004","volume":"57","author":"RY Calne","year":"1994","unstructured":"Calne, R. Y.  et al. Tolerance of porcine renal allografts induced by donor spleen cells and seven days' treatment with cyclosporine. Transplantation 57, 1433\u20131435 (1994).","journal-title":"Transplantation"},{"key":"BFnrcardio201363_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.healun.2012.11.022","volume":"32","author":"S Urschel","year":"2013","unstructured":"Urschel, S.  et al. ABO-incompatible heart transplantation in early childhood: an international multicenter study of clinical experiences and limits. J. Heart Lung Transplant. 32, 285\u2013292 (2013).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio201363_CR28","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1097\/TP.0b013e31818fff64","volume":"86","author":"T Becker","year":"2008","unstructured":"Becker, T.  et al. Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation 86, 1689\u20131694 (2008).","journal-title":"Transplantation"},{"key":"BFnrcardio201363_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/SLA.0b013e31826d90bb","volume":"257","author":"S Schneeberger","year":"2013","unstructured":"Schneeberger, S.  et al. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann. Surg. 257, 345\u2013351 (2013).","journal-title":"Ann. Surg."},{"key":"BFnrcardio201363_CR30","unstructured":"US Department of Health & Human Sciences: FDA. Important drug information \n                    [online]\n                    \n                  , (2009)."},{"key":"BFnrcardio201363_CR31","unstructured":"Clinical Trials in Organ Transplantation. Approved studies \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio201363_CR32","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jacc.2011.11.050","volume":"59","author":"MR Shah","year":"2012","unstructured":"Shah, M. R., Starling, R. C., Schwartz Longacre, L. & Mehra, M. R. Heart transplantation research in the next decade\u2014a goal to achieving evidence-based outcomes: National Heart, Lung, and Blood Institute Working Group. J. Am. Coll. Cardiol. 59, 1263\u20131269 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201363_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","volume":"24","author":"HJ Eisen","year":"2005","unstructured":"Eisen, H. J.  et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J. Heart Lung Transplant. 24, 517\u2013525 (2005).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio201363_CR34","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.transproceed.2004.12.135","volume":"37","author":"J Kobashigawa","year":"2005","unstructured":"Kobashigawa, J.  et al. Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids. Transplant. Proc. 37, 1333\u20131339 (2005).","journal-title":"Transplant. Proc."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2013.63.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2013.63","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2013.63.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:53:18Z","timestamp":1684468398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2013.63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFnrcardio201363"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2013.63","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,30]]}}}